CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 vs HeartFlow Analysis
AI Verdict
Choose CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 if…
Choose CARTO™ 3 EP Navigation System Software V8.0 if your primary need is real-time, AI-powered 3D cardiac mapping and catheter navigation during electrophysiology procedures. This tool is ideal for electrophysiologists performing ablation for complex arrhythmias like AFib and VT, requiring advanced signal analysis and precise catheter visualization to guide treatment.
View CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 →Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a non-invasive, AI-driven solution for diagnosing and managing coronary artery disease (CAD) based on standard CT scans. This tool is best suited for assessing the functional impact of coronary stenoses and characterizing plaque, providing personalized 3D models and FFRct values to inform treatment decisions without invasive procedures.
View HeartFlow Analysis →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 | HeartFlow Analysis |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | On-premise (system with specialized hardware) | Cloud-based (AWS) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CARTO 3 EP Navigation System Software V8.0 (FG-5400-00CARTO 3's latest version significantly enhances usability during complex electrophysiology procedures by leveraging AI for automated 3D left atrial anatomy creation, eliminating manual contouring and streamlining workflow. Its features, such as fast anatomical mapping and automatic catheter recognition, directly reduce manual steps and improve efficiency in a high-stakes surgical environment.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis demonstrates superior clinical value by providing a non-invasive solution for diagnosing coronary artery disease with high accuracy, which has been shown to significantly decrease cardiovascular mortality and reduce the need for additional invasive testing. Its FFRct and Plaque Analysis offer critical insights that guide treatment decisions and improve cath lab efficiency.
Pricing & Value
HeartFlow AnalysisHeartFlow offers clear pricing and value with an established fee-for-service model, broad coverage by Medicare and most U.S. commercial payers, and dedicated Category I CPT codes. This transparency and established reimbursement pathway significantly de-risk adoption for healthcare providers and demonstrate tangible economic value through cost savings.
Enterprise Readiness
HeartFlow AnalysisHeartFlow's fully cloud-based deployment on AWS offers greater enterprise readiness through enhanced scalability, easier integration with existing hospital IT infrastructure like PACS and EMRs, and reduced on-premise IT overhead. This contrasts with CARTO 3's on-premise system, even with optional cloud storage, which may require more significant local IT management.
Innovation
TieBoth tools are highly innovative in their respective fields. CARTO 3 brings real-time AI and automation to complex invasive electrophysiology procedures, enhancing efficiency and accuracy during live interventions. HeartFlow pioneered the non-invasive assessment of coronary artery disease using AI and computational fluid dynamics to derive FFRct, fundamentally changing the diagnostic pathway and potentially avoiding invasive procedures.
Support & Docs
HeartFlow AnalysisHeartFlow provides a more comprehensive and explicitly detailed support structure, including dedicated specialists for program enhancement, hands-on training, technology integration, expert coding and reimbursement support, and educational resources through HeartFlow University. This holistic approach extends beyond technical assistance to operational and financial aspects.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 | HeartFlow Analysis |
|---|---|---|
| Name | CARTOu2122 3 EP Navigation System Software V8.0 (FG-5400-00 | HeartFlow Analysis |
| Company | Biosense Webster, Inc. | HeartFlow |
| Primary Application | FDA-cleared, AI-powered 3D cardiac mapping and navigation system for electrophysiologists, enhancing diagnosis and treatment of heart rhythm disorders like AFib and VT. | Non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. |
| Key AI/ML Functionality | CARTO ELEVATEu2122 Module with machine learning for enhanced signal analysis; CARTOSOUNDu2122 FAM Module utilizing AI/deep-learning for automated 3D left atrial anatomy creation. | AI-powered 3D modeling of coronary arteries; AI-Enabled Quantitative Plaque Analysis; Computational Fluid Dynamics (CFD) for blood flow simulation. |
| Target Specialty | Cardiology (specifically electrophysiologists) | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 and HeartFlow Analysis.